{"name":"Therapeutics, Inc.","slug":"therapeutics-inc","ticker":"","exchange":"","domain":"terapeutica.ro","description":"Therapeutics, Inc. is a biopharmaceutical company focused on the development of innovative treatments for various dermatological conditions. With a pipeline of 16 drugs, the company is advancing several candidates through early-stage clinical trials, including Halobetasol Proprionate Lotion 0.05% and UHE-103 Cream.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":226579563,"revenueGrowth":0,"grossMargin":0,"rdSpend":82050392,"netIncome":98293213,"cash":286428371,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"UHE-103A2 cream","genericName":"UHE-103A2 cream","slug":"uhe-103a2-cream","indication":"Other","status":"phase_2"},{"name":"UHE-105","genericName":"UHE-105","slug":"uhe-105","indication":"Other","status":"phase_2"},{"name":"UHE-101 Cream","genericName":"UHE-101 Cream","slug":"uhe-101-cream","indication":"Other","status":"phase_2"},{"name":"UHE-103A1B cream","genericName":"UHE-103A1B cream","slug":"uhe-103a1b-cream","indication":"Other","status":"phase_2"},{"name":"UHE-103A2B cream","genericName":"UHE-103A2B cream","slug":"uhe-103a2b-cream","indication":"Other","status":"phase_2"},{"name":"UHE-103B cream","genericName":"UHE-103B cream","slug":"uhe-103b-cream","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"UHE-103A2 cream","genericName":"UHE-103A2 cream","slug":"uhe-103a2-cream","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"UHE-105","genericName":"UHE-105","slug":"uhe-105","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"UHE-101 Cream","genericName":"UHE-101 Cream","slug":"uhe-101-cream","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"UHE-103A1B cream","genericName":"UHE-103A1B cream","slug":"uhe-103a1b-cream","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"UHE-103A2B cream","genericName":"UHE-103A2B cream","slug":"uhe-103a2b-cream","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"UHE-103B cream","genericName":"UHE-103B cream","slug":"uhe-103b-cream","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1MZWhHRmstY3hVSWdvYTFkZEgxeGU0WTh1T1IzbzJ1VzVBVEZna1BlQm9faW9tdnFaLVEtc1ZHeWlYN0djR3VWZ1k1bUl2VVlxNVE?oc=5","date":"2026-04-08","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxOTWRKUFFxSkZqdnVqMGlXaEVwaWtLV0dJc21RU2tqeGZpSzhhbEplcWFNUG8zVlk4OE9UVW56VmY0NmJkYjJTTTE0M3oxNlhteE1pNk1IQXhzZzVmTTZYNkVFR2tXMmlDdl84c1c5RHBSQU4wTDFhNzlCVDY5SldIcTBreHg0NnlRR0E0Q0hNM2xMRU43bXMwS0lkbGRKSzhHY2pWVkw2T29zd2w5TEItSW1uQjE5ejVOcmdZNWRQOTZfeFZyUEZucG9jZlZUMk9DMkhacVVPVngyU19ia04tUV9KZTZjM2duUldRN1Yzb2NraTB3VW5mbm9odEpJSEZxS2NvOWlZLThzaTRaWF9uZE9IRmVXd0d2YXVmRUhIOEtIaVItOVJzSGF6M0hDY3dENVhDODQzMzZ6U1BkWWlOdDM5Q2U?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"Diabetes Market: Rapid Increment Driven by Innovation by 2032 – DelveInsight | Eli Lilly and Company, Regor Pharma AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova - Barcha","headline":"Diabetes Market: Rapid Increment Driven by Innovation by 2032 – DelveInsight | Eli Lilly and Company, Regor Pharma Astra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNa1p1WVlyeXF6MHNwUXJuMF9DR3JIazI1QnFXYWJlZ1VZeXU5cHZBVHFBNWh6VUVCZXAwcTZ3V0dnSXFUR0NIRXZtWlh5RnhTY1pKWEMtdmpaOW9iSFBoTk5CQlRuUk9IVDN1anc2Zm11WEU1TXd4ek5SYVROb3RPZHZoeDBKeHd3aEh4OE9JSVlleVdXa2c?oc=5","date":"2026-04-08","type":"regulatory","source":"Yahoo Finance Singapore","summary":"ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet - Yahoo Finance Singapore","headline":"ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOQndHZ2psTWVUNFJxOFd0TzdCTmRRUGh4am90RXhNQXRXMEVJbWxzTVRhWFdpTzlsMkc1WTd0X1JxNVdPemd1TDBUa0pjM0h4UnR0RmhtbGk2Uk5sSE1ZQ1BWNlRlVEpMazhwV25iRHVTNy1mMThxUmVBblp4TFlZZVduUnluYlV6VlJ4NzVQQ1ppWVZhYlJZdTVPcWZGanF4a3VQTjllUGprdTk0MEZiZlFlb1RUbE5CS2VwbWtmaXpzUThieWlwQWJPNjQyRHkxQk92S1RqamtYVGNoZmcwNS1QTjNoRXItTHNvM3hkYjFUU2ZLQm9nZmhldmlYZw?oc=5","date":"2026-04-07","type":"deal","source":"PR Newswire","summary":"Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology - PR Newswire","headline":"Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQZzlWZGFNcGh3V3ZTMXhiZ0VHZTlpVTUyS1pac1c5VkZ4STk1bG96Vjg5UURKdW5OcjFFdE9lWThZTXhLY3VvbnA5S3FRdWlUV3NkcGxwTE9pQ3l4Q0ZmcXJJR25hVE9OWEJlR2toaWNFRHZIVEU2eFlHTEdFTEtUU3dvbHNpQTV4LWdVWlVGdmhVZi1oTUstNXc4OGdmNGZBeGtuYUJfcTJid3ZBamt2N1Z4a3hLaHpVYWZCbWIwR0wtMC0xbTBPejNhNWxmY2ZBZTFCUTAxb1YxOWlhYXE1VnZCZldjOUtzSExIV2c5RnE1Um5qRDlDeUtOS2lEWFVCT2lWUUdwb0lJRHRwUVRGdV9QbE9DNkw2TC1lX2E2MTRQeTQzTElGRGlzUFo3cnNOVnM3dGxzVnhDWEZOWkN1X2tOejFISUk?oc=5","date":"2026-04-07","type":"trial","source":"GlobeNewswire","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxNeUpIQXNZVy04VUptaGd1dDRMa1YwWjRHQTdsUXg2R1RuV0xlX2g5M1diZFpXNmszX1pIMjJ6SERvcmpaN1RlRmtBSWtITVVMVERMcU55UHVsZzUxTDRoVVhsZ3lpQmJVM2psYzRWZ0ZzbTF1YzJKcUM2WDRXNlJtQTZOb1NXSDJkUW9kZl9iUXE0SDNMX2htMklDd2dGNmlCbkN1c2ZpOVp2VlNzZzItS1ZBSUstclUyQ1IxcHVKYTkwUDQxRl94eVRLZnlRVEN2RGtBbnkyalNINEJucV96Vy1XTXpDWk9IdGdPdWVOVkZadGVvY21hYlRGLTdJSklnNGpuSmNKX0ZwcTJuSmJtbmJhQUtrTmthQkVINmtoWFVUWEU1ZmJZU1IwTklKX3N4Tm5rVGtuN1NMQWFqbFQ1YXh2dVZmWENTemthWm1IZw?oc=5","date":"2026-04-07","type":"regulatory","source":"Barchart.com","summary":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeutics, Disease Prevalence, Mechanisms, Market Size, Key Companies | DelveInsight -","headline":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeut","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxPN1J6NWg0MXEzM2cxWEo5bzA4SmJuRFZtN19YTENza1JjVkFVUEJ4bFlGMFBXV2hLRUpNUWQtTWR3R21FQWpfS1d5WEdBZEU4eHp4VElVb0p6c0dSLWtDRDFPZ0FFbGtnNy1neTd4U1g5MWF1Z2lWaEhfTDk0Ymh3cEVrSEI1STl5akpNQzZnNDVHY1lyQ2Z2c2htN2VuMnI4OFYyejNQWnZVOU1kRUQ1YjRYczROUGh2NTRlajhMWFRWUVZXVTdIOE81QTNOZndxMUhlN09Wci10enZEOVhnTGZnWGtodW9rVHdFdl9QZ1FFREZlSmx2YV9Ob01BeWlWcV9HVGo1a2NBV2EwaEVLa0VXUQ?oc=5","date":"2026-04-06","type":"regulatory","source":"GlobeNewswire","summary":"NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling - GlobeNewswire","headline":"NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQOE5yNTlzRVdGdTZUTmZ1Qk10NWdqa1ROQWRoQUpZYzFKSFVpTTR0YTF6MmxrQzdRbUFldkZUOVhqb29JdmtRdm83UmJDTmx0d2txeEpqNWpXUGdVYnpLVDBtU0MtRkR2cTFjZWpFcEplUGJaUjFGZ1U1M0tJeHdRcmo1eVlKcjRDa0tYd29B?oc=5","date":"2026-03-03","type":"deal","source":"Pharmaceutical Technology","summary":"Kairos Pharma signs deal for Celyn Therapeutics’ CL-273 - Pharmaceutical Technology","headline":"Kairos Pharma signs deal for Celyn Therapeutics’ CL-273","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNSVo2S2NrejZMeWpvQ0tGZnhDVmFmRlVfbVVQWUx2MkZ3NjdSOUtteUk5aDBFODB2X01Ja2hxYzByOVBIVTVXOGkxdVV4alRMZ0pRUFI3UlpvLU5ZMm9vZ1o2MnRrVmo5TnpsT3h2Z0x1SmJPc3pnbmRFMGFlMUE0ekh2RmpPLURZVUhyb0pueG90bkhQOTlZdmZOZUw1OG5icDNzQmQyYkU5a2V4dU5DQjlzZmhGSzFCdXZMSWNkaEUxUQ?oc=5","date":"2026-02-03","type":"pipeline","source":"Business Wire","summary":"Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics - Business Wire","headline":"Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNaEtWTnJaV01rSThxdkpsU2d5QjI1UHJrbFZFU0YySlFwSnRiU19paHBDY0tIWklpSXlxMlpKZHBrZldDVFd4b3ZwYk9XTXZ6ODg1dTJnWGF1cmlSWkR4bnhvRjJmcVd5OHdFa2JMTWFJQWoxZ2pyNUxMWmJFUFVpQkZFaXNIUnc3T3JwbzI2SFlMcFI0ZW9reFYyVzY?oc=5","date":"2026-02-03","type":"deal","source":"Contract Pharma","summary":"Cycle Group Holdings Acquires Applied Therapeutics - Contract Pharma","headline":"Cycle Group Holdings Acquires Applied Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNS1dnSDhvcEx3cXFYaHRnbXVZdVpyX2RKdWZUTEFfbjE1d0FIYnNrMVNmMmpIcWcxUkNPVDY1OUExSmIyNGw1SmsxSmZWby1QWVVFMkhCRVZxd0FTeVdrR3N3VzFPTFNxQjVzV1oyZWNZc1VoazVpdWNZRkMzQ3dzanJuSVhITWtUZXVpbFNZcWtWVmFDbWpFU3NrYUdSYThCRnVmOHJOdjZLRGpMc3hOZlhJd0JFSjNCZ25OTklBRC1peTRzYWNZcFhOYmN4UkM3?oc=5","date":"2026-01-30","type":"pipeline","source":"Business Wire","summary":"Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer - Business Wire","headline":"Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQZlRSb2ZwUDVUNDFueVlvbXlMTTNqMTZfY3RhTmZTa0RiYUtSZmI3VjQzYVNhcTJHU0hkNU9aT0FXenhrM1NfdHM4TTZiUnM2N2h0SmZ2YzBXWHd2WWZBMHpBRTFycERFak4zRVF2WHFDMGc0bjhPWEF6MURWLVRqckdpUVVPR1g3WnV3Z1llVHVseUU4MUlvNnFoTW85U3g5WGV0amhMN3l3NTFpTkFxZTROZUJxRVVDdUNlMERVREZ6eEtnSjZzLTlualQ?oc=5","date":"2026-01-07","type":"trial","source":"PR Newswire","summary":"Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development - PR Newswire","headline":"Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_2":6},"enrichmentLevel":3,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":226579563,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":226579563,"period":"2022-12-31"},{"value":0,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":82050392,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":98293213,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":286428371,"cashHistory":[],"totalAssets":578322736,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}